Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus

This publication has 18 references indexed in Scilit:

• Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Statins and Cancer Risk
  The American Journal of Medicine, 2008
• Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial
  JNCI: Journal of the National Cancer Institute, 2007
• Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence
  Alimentary Pharmacology & Therapeutics, 2006
• Daily use of non‐steroidal anti‐inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma
  Alimentary Pharmacology & Therapeutics, 2004
• Trends in Incidence and Prevalence of Specialized Intestinal Metaplasia, Barrett’s Esophagus, and Adenocarcinoma of the Gastroesophageal Junction
  World Journal of Surgery, 2003
• Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
  Gastroenterology, 2003
• 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of Cancer
  Archives of internal medicine (1960), 2000
• Barrett's oesophagus and proton pump inhibitors: a pathological perspective
  Gut, 2000
• Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
  New England Journal of Medicine, 1999